Stanford University-led researchers report that tumor cells hijack mitochondria from immune cells, reducing anti-tumor immune ...
TUCSON, AZ / ACCESS Newswire / January 17, 2026 / Umbrella Labs today announced expanded availability of MOTS-c in a 10 mg vial format sold strictly for laboratory research use only, supporting ...
Mitochondrial dysfunction is associated with various chronic diseases and cancers, including neurodegenerative diseases and ...
Prof. Ciro Leonardo Pierri's expertise in structural biology, mitochondrial carrier modeling, and drug targeting—demonstrated ...
New Review Integrates Human, Animal, and Cellular Evidence to Reframe AD as a Triad-Centered Disorder Alzheimer’s disease (AD ...
Hijacking the energy-producing organelles from immune cells seems to help tumours in mice to infiltrate lymph nodes.
Mitochondrial respiratory complexes (Complexes I–V) and their assembly into respiratory supercomplexes (SCs) are fundamental to liver bioenergetics, redox homeostasis, and metabolic adaptability.
U.S. Patent No. 12,329,781 relates to Minovia’s proprietary mitochondrial augmentation technology for the treatment of renal diseases, including renal tubulopathy, kidney insufficiency, and chronic ...
The first healthy volunteers have been dosed in an early clinical trial testing NRG5051, a disease-modifying therapy for ALS ...
Management of mitochondrial-related heart disease relies on multidisciplinary care and symptom control, as targeted gene-editing therapies are limited.
A National Taiwan University study reveals how intracellular bacteria co-opt mitochondrial transporters to evade immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback